Renaissance Group LLC Has $621,000 Holdings in Chemed Co. (NYSE:CHE)

Renaissance Group LLC cut its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 97.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,172 shares of the company's stock after selling 48,798 shares during the period. Renaissance Group LLC's holdings in Chemed were worth $621,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in CHE. UMB Bank n.a. increased its position in Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company's stock worth $28,000 after acquiring an additional 39 shares during the period. Atala Financial Inc bought a new position in shares of Chemed during the fourth quarter worth approximately $29,000. CBIZ Investment Advisory Services LLC raised its position in shares of Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after buying an additional 22 shares in the last quarter. Trust Co. of Vermont bought a new position in Chemed during the 4th quarter worth $34,000. Finally, Tortoise Investment Management LLC raised its holdings in Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock valued at $41,000 after acquiring an additional 34 shares in the last quarter. Institutional investors own 95.85% of the company's stock.

Chemed Price Performance

Shares of NYSE CHE traded up $1.69 during mid-day trading on Monday, hitting $595.08. 17,766 shares of the stock traded hands, compared to its average volume of 112,147. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $625.09. The firm has a 50 day simple moving average of $583.16 and a two-hundred day simple moving average of $567.72. The company has a market cap of $8.70 billion, a PE ratio of 30.07, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49.

Remove Ads

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. Chemed's dividend payout ratio (DPR) is presently 10.05%.

Analyst Ratings Changes

Several research firms recently weighed in on CHE. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada lifted their target price on Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a research report on Friday, March 14th.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the transaction, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 3.32% of the stock is owned by company insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.